Compared to primary melanoma lesions, lymph node metastases have been demonstrated to have higher levels of indoleamine 2,3-dioxygenase (IDO), interleukin (IL)-10, regulatory T cells, and tolerogenic dendritic cells, which have the combined effect of creating an immunotolerant environment [67]. This evidence concerns the gene IDO1 and melanoma.